Added to YB: 2024-02-15
Pitch date: 2024-02-15
ABEO [bullish]
Abeona Therapeutics Inc.
-28.35%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
Market Cap
$292.2M
Pitch Price
$6.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.08
P/E
-4.32
EV/Sales
6.48
Sector
Biotechnology
Category
N/A
Show full summary:
ABEONA THERAPEUTICS INC ABEO
A summary for this pitch has not been created yet.
Read full article (0 min)